US$ 27.36
astria therapeutics glp-1 receptor agonist weight management diabetes treatments The Agonists and Obesity: How Drugs are Changing Non-Diabetic Lives — tl;dr pharmacy Evolution of GLP‐1 Receptor Agonists
Description
Phytomedicine as a source of SGLT2 inhibitors, GLP-1 secretagogues and DPP-IV inhibitors for mitigation of diabetic nephropathy

Importantly, individuals with T2DM continue to benefit from GLP- 1's glucose-lowering effects

Nachnani JS, Bulchandani DG, Nookala A, Herndon B, Molteni A, Pandya P, Taylor R, Quinn T, Weide L, and Alba LM

This expectation was verified based on findings of this study

Hirano T, Mori Y
